SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas to participate in panel discussion on "The Impact of Globalization in Healthcare" at the North Carolina Biotechnology Center.
News | 08. 15. 2006
